If no BCR-ABL1 fusion can be detected by FISH, and CML is still clinically suspected, then RT-PCR and/or molecular testing for mutations associated with other myeloproliferative neoplasms (MPN) is required (see MPN section below). Here, ABL1 is linked to myeloproliferative neoplasm.